to total revenues (%) 1.35% 1.52% 2.11% Net profit million baht 2,952 5,126 4,929 %hange of net profitC (%) (42.42%) 4.00% (10.64%) Net profit margin (%) 5.77% 9.66% 10.00% profit to total revenuesNet
) (667.08) (419.93) (68,840.98) Income tax - - - - Annum net loss (272.97) (667.08) (419.93) (68,840.98) Parent company’s loss (272.97) (667.08) (419.61) (68,788.52) For the Company’s performance pursuant to
(61.85) (322.30) (64.23) (10,529.51) Total expenses (181.17) (944.09) (286.38) (46,947.54) Profit (Loss) before tax (172.69) (899.90) (274.97) (45,077.05) Tax - - - - Net Profit (loss) for the period
DCORP 025/2020 May 13, 2020 Subject: Management Discussion and Analysis – Explanation of net profit for the quarter ended March 31, 2020 and the increase in the overall operations of more than 20 percent
Business having more marketing promotions and advertising expenses so to drive increased sales revenues together with the expansion of the outlets network compared to the same period last year by (net) 40
underwriting amounted to Baht 7.95 million, an increase of Baht 16.08 million, as the ratio of net claims (less claim recovery from reinsurers) over earned premium during the same period last year decreased from
consolidated financial statement, the Company booked a net loss amounting to Baht 16.36 million, representing an increase in a net loss of Baht 0.52 million or 3.25% from a net loss of Baht 15.84 million booked
and Service 494.92 368.98 125.93 34.13% Total Revenue 497.71 371.79 125.91 33.87% Net Profit for the Period 98.53 54.37 44.16 81.23% Net Profit for Shareholders of the Company 80.46 46.88 33.58 71.62
greater export sales portion. 3. In Q3 2017, the Company and its subsidiaries recorded the assets’ impairment loss and write- off of Solvay Biochemicals (Taixing) Limited (“SBT”) net amounting to 132 MB
Baht to 66.02 Million Baht or 13.95%, due to corporate marketing and sales alignment. 2. Our net loss for Q3 is 3.17 Million Baht compare to net loss 5.32 Million Baht Q on Q, due to decreasing in